0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Radiopharmaceuticals Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
Published Date: January 2022
|
Report Code: QYRE-Othe-1Y270
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
radiopharmaceuticals market

Global Radiopharmaceuticals Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Code: QYRE-Othe-1Y270
Report
January 2022
Pages:117
QYResearch
Description
Table of Content
Tables & Figures

Radiopharmaceuticals Market Growth - 2027

In 2020, the global Radiopharmaceuticals market size was US$ 6260.1 million and it is expected to reach US$ 10730 million by the end of 2027, with a Compound Annual Growth Rate (CAGR) of 8.0% during the forecast period 2021-2027. An increase in the number of cancer cases and cardiovascular disease, growing demand for targeted cancer treatment dependent on alpha radioimmunotherapy, increasing demand for nuclear imaging techniques, and developments in radiotracer treatment are anticipated to boost the radiopharmaceuticals market size.
 
Radiopharmaceuticals Market Research Report
 
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
 
Radiopharmaceuticals play an important role in the treatment of different diseases by providing a deeper understanding of the staging of diseases. Radiopharmaceuticals linked to chemical compounds allow the analysis of a particular physiological cycle. Advantages such as high efficacy and noninvasive external monitoring are expected to increase the radiopharmaceutical's market size.
 
North America is expected to hold the largest radiopharmaceuticals market share. The significant share can be attributed to the advancement of innovative technologies in the region for the manufacture of radioisotopes, government support, and company initiatives.
 
The major players in the global Radiopharmaceuticals market include Bracco Imaging, Bayer, Mallinckrodt, etc. The top 3 players hold over 40% of global market shares. North America and Europe are the main markets, they occupy over 70% of the global market. Diagnostic Radioisotopes is the main type, with a share of about 90%. Oncology is the key application, which holds over 60% of shares.

Radiopharmaceuticals Market Segment Outlook

The radiopharmaceuticals market is segmented by region, country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027. 

Radiopharmaceuticals Market by Type

Radiopharmaceuticals Market by Application

  • Oncology
  • Cardiology
  • Other

Radiopharmaceuticals Market by Region

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Australia
  • Rest of Asia-Pacific
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Major Players in the Radiopharmaceuticals Market

  • Bracco Imaging
  • Bayer
  • Mallinckrodt
  • Nordion
  • Triad Isotopes
  • Lantheus
  • IBA Group
  • GE Healthcare
  • China Isotope & Radiation
  • Jubilant Pharma
  • Eli Lilly
  • Advanced Accelerator Applications
  • SIEMENS
  • Dongcheng
  • Navidea

Scope of the Radiopharmaceuticals Market Report

Report Metric

Details

Report Name

Radiopharmaceuticals Market

The market size in 2020

USD 6260.1 Million

The revenue forecast in 2027

USD 10730 Million

Growth Rate

Compound Annual Growth Rate (CAGR) of 8.0% from 2021 to 2027

Market size available for years

2021-2027

Forecast units

Value (USD)

Segments covered

Type, End-User, Offerings, and Region

Report coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Geographic regions covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Frequently Asked Questions About This Report

1. What is the current size of the global radiopharmaceuticals market?

Ans. In 2020, the global Radiopharmaceuticals market size was US$ 6260.1 million and it is expected to reach US$ 10730 million by the end of 2027, with a Compound Annual Growth Rate (CAGR) of 8.0% during 2021-2027

2. Which segment accounted for the largest radiopharmaceuticals market share?

Ans. Diagnostic Radioisotopes Segment is the main type, with a share about 90%. Oncology is the key application, which holds over 60% of shares.

3. Which region is and will provide more business opportunities for radiopharmaceuticals in future?

Ans. North America and Europe are the main markets, they occupy over 70% of the global radiopharmaceuticals market share.

4. How can I get report sample of radiopharmaceuticals market?

Ans. To get latest version of radiopharmaceuticals market report can be obtained on demand from the website.

5. What are the new market trends impacting the growth of the radiopharmaceuticals market?

Ans. Increasing demand for nuclear imaging techniques, and developments in radiotracer treatment are anticipated to boost the radiopharmaceuticals market growth.

1 Study Coverage
1.1 Radiopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global Radiopharmaceuticals Market Size Growth Rate by Type
1.2.2 Diagnostic Radioisotopes
1.2.3 Therapeutic Radioisotopes
1.3 Market by Application
1.3.1 Global Radiopharmaceuticals Market Size Growth Rate by Application
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceuticals Market Size Estimates and Forecasts
2.1.1 Global Radiopharmaceuticals Revenue 2016-2027
2.1.2 Global Radiopharmaceuticals Sales 2016-2027
2.2 Radiopharmaceuticals Market Size by Region: 2021 Versus 2027
2.3 Radiopharmaceuticals Sales by Region (2016-2027)
2.3.1 Global Radiopharmaceuticals Sales by Region: 2016-2021
2.3.2 Global Radiopharmaceuticals Sales Forecast by Region (2022-2027)
2.3.3 Global Radiopharmaceuticals Sales Market Share by Region (2016-2027)
2.4 Radiopharmaceuticals Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Radiopharmaceuticals Revenue by Region: 2016-2021
2.4.2 Global Radiopharmaceuticals Revenue Forecast by Region (2022-2027)
2.4.3 Global Radiopharmaceuticals Revenue Market Share by Region (2016-2027)
3 Global Radiopharmaceuticals by Manufacturers
3.1 Global Top Radiopharmaceuticals Manufacturers by Sales
3.1.1 Global Radiopharmaceuticals Sales by Manufacturer (2016-2021)
3.1.2 Global Radiopharmaceuticals Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Radiopharmaceuticals Manufacturers by Revenue
3.2.1 Global Radiopharmaceuticals Revenue by Manufacturer (2016-2021)
3.2.2 Global Radiopharmaceuticals Revenue Share by Manufacturer (2016-2021)
3.3 Global Radiopharmaceuticals Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
3.4.2 Global Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Radiopharmaceuticals Manufacturing Base Distribution, Product Type
3.5.1 Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Radiopharmaceuticals Product Type
3.5.3 Date of International Manufacturers Enter into Radiopharmaceuticals Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Bracco Imaging
4.1.1 Bracco Imaging Corporation Information
4.1.2 Bracco Imaging Description, Business Overview
4.1.3 Bracco Imaging Radiopharmaceuticals Products Offered
4.1.4 Bracco Imaging Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.1.5 Bracco Imaging Radiopharmaceuticals Revenue by Product
4.1.6 Bracco Imaging Radiopharmaceuticals Revenue by Application
4.1.7 Bracco Imaging Radiopharmaceuticals Revenue by Geographic Area
4.1.8 Bracco Imaging Radiopharmaceuticals Revenue by Sales Channel
4.1.9 Bracco Imaging Recent Development
4.2 Bayer
4.2.1 Bayer Corporation Information
4.2.2 Bayer Description, Business Overview
4.2.3 Bayer Radiopharmaceuticals Products Offered
4.2.4 Bayer Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Bayer Radiopharmaceuticals Revenue by Product
4.2.6 Bayer Radiopharmaceuticals Revenue by Application
4.2.7 Bayer Radiopharmaceuticals Revenue by Geographic Area
4.2.8 Bayer Radiopharmaceuticals Revenue by Sales Channel
4.2.9 Bayer Recent Development
4.3 Mallinckrodt
4.3.1 Mallinckrodt Corporation Information
4.3.2 Mallinckrodt Description, Business Overview
4.3.3 Mallinckrodt Radiopharmaceuticals Products Offered
4.3.4 Mallinckrodt Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Mallinckrodt Radiopharmaceuticals Revenue by Product
4.3.6 Mallinckrodt Radiopharmaceuticals Revenue by Application
4.3.7 Mallinckrodt Radiopharmaceuticals Revenue by Geographic Area
4.3.8 Mallinckrodt Radiopharmaceuticals Revenue by Sales Channel
4.3.9 Mallinckrodt Recent Development
4.4 Nordion
4.4.1 Nordion Corporation Information
4.4.2 Nordion Description, Business Overview
4.4.3 Nordion Radiopharmaceuticals Products Offered
4.4.4 Nordion Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Nordion Radiopharmaceuticals Revenue by Product
4.4.6 Nordion Radiopharmaceuticals Revenue by Application
4.4.7 Nordion Radiopharmaceuticals Revenue by Geographic Area
4.4.8 Nordion Radiopharmaceuticals Revenue by Sales Channel
4.4.9 Nordion Recent Development
4.5 Triad Isotopes
4.5.1 Triad Isotopes Corporation Information
4.5.2 Triad Isotopes Description, Business Overview
4.5.3 Triad Isotopes Radiopharmaceuticals Products Offered
4.5.4 Triad Isotopes Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Triad Isotopes Radiopharmaceuticals Revenue by Product
4.5.6 Triad Isotopes Radiopharmaceuticals Revenue by Application
4.5.7 Triad Isotopes Radiopharmaceuticals Revenue by Geographic Area
4.5.8 Triad Isotopes Radiopharmaceuticals Revenue by Sales Channel
4.5.9 Triad Isotopes Recent Development
4.6 Lantheus
4.6.1 Lantheus Corporation Information
4.6.2 Lantheus Description, Business Overview
4.6.3 Lantheus Radiopharmaceuticals Products Offered
4.6.4 Lantheus Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.6.5 Lantheus Radiopharmaceuticals Revenue by Product
4.6.6 Lantheus Radiopharmaceuticals Revenue by Application
4.6.7 Lantheus Radiopharmaceuticals Revenue by Geographic Area
4.6.8 Lantheus Recent Development
4.7 IBA Group
4.7.1 IBA Group Corporation Information
4.7.2 IBA Group Description, Business Overview
4.7.3 IBA Group Radiopharmaceuticals Products Offered
4.7.4 IBA Group Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.7.5 IBA Group Radiopharmaceuticals Revenue by Product
4.7.6 IBA Group Radiopharmaceuticals Revenue by Application
4.7.7 IBA Group Radiopharmaceuticals Revenue by Geographic Area
4.7.8 IBA Group Recent Development
4.8 GE Healthcare
4.8.1 GE Healthcare Corporation Information
4.8.2 GE Healthcare Description, Business Overview
4.8.3 GE Healthcare Radiopharmaceuticals Products Offered
4.8.4 GE Healthcare Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.8.5 GE Healthcare Radiopharmaceuticals Revenue by Product
4.8.6 GE Healthcare Radiopharmaceuticals Revenue by Application
4.8.7 GE Healthcare Radiopharmaceuticals Revenue by Geographic Area
4.8.8 GE Healthcare Recent Development
4.9 China Isotope & Radiation
4.9.1 China Isotope & Radiation Corporation Information
4.9.2 China Isotope & Radiation Description, Business Overview
4.9.3 China Isotope & Radiation Radiopharmaceuticals Products Offered
4.9.4 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.9.5 China Isotope & Radiation Radiopharmaceuticals Revenue by Product
4.9.6 China Isotope & Radiation Radiopharmaceuticals Revenue by Application
4.9.7 China Isotope & Radiation Radiopharmaceuticals Revenue by Geographic Area
4.9.8 China Isotope & Radiation Recent Development
4.10 Jubilant Pharma
4.10.1 Jubilant Pharma Corporation Information
4.10.2 Jubilant Pharma Description, Business Overview
4.10.3 Jubilant Pharma Radiopharmaceuticals Products Offered
4.10.4 Jubilant Pharma Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.10.5 Jubilant Pharma Radiopharmaceuticals Revenue by Product
4.10.6 Jubilant Pharma Radiopharmaceuticals Revenue by Application
4.10.7 Jubilant Pharma Radiopharmaceuticals Revenue by Geographic Area
4.10.8 Jubilant Pharma Recent Development
4.11 Eli Lilly
4.11.1 Eli Lilly Corporation Information
4.11.2 Eli Lilly Description, Business Overview
4.11.3 Eli Lilly Radiopharmaceuticals Products Offered
4.11.4 Eli Lilly Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.11.5 Eli Lilly Radiopharmaceuticals Revenue by Product
4.11.6 Eli Lilly Radiopharmaceuticals Revenue by Application
4.11.7 Eli Lilly Radiopharmaceuticals Revenue by Geographic Area
4.11.8 Eli Lilly Recent Development
4.12 Advanced Accelerator Applications
4.12.1 Advanced Accelerator Applications Corporation Information
4.12.2 Advanced Accelerator Applications Description, Business Overview
4.12.3 Advanced Accelerator Applications Radiopharmaceuticals Products Offered
4.12.4 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.12.5 Advanced Accelerator Applications Radiopharmaceuticals Revenue by Product
4.12.6 Advanced Accelerator Applications Radiopharmaceuticals Revenue by Application
4.12.7 Advanced Accelerator Applications Radiopharmaceuticals Revenue by Geographic Area
4.12.8 Advanced Accelerator Applications Recent Development
4.13 SIEMENS
4.13.1 SIEMENS Corporation Information
4.13.2 SIEMENS Description, Business Overview
4.13.3 SIEMENS Radiopharmaceuticals Products Offered
4.13.4 SIEMENS Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.13.5 SIEMENS Radiopharmaceuticals Revenue by Product
4.13.6 SIEMENS Radiopharmaceuticals Revenue by Application
4.13.7 SIEMENS Radiopharmaceuticals Revenue by Geographic Area
4.13.8 SIEMENS Recent Development
4.14 Dongcheng
4.14.1 Dongcheng Corporation Information
4.14.2 Dongcheng Description, Business Overview
4.14.3 Dongcheng Radiopharmaceuticals Products Offered
4.14.4 Dongcheng Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.14.5 Dongcheng Radiopharmaceuticals Revenue by Product
4.14.6 Dongcheng Radiopharmaceuticals Revenue by Application
4.14.7 Dongcheng Radiopharmaceuticals Revenue by Geographic Area
4.14.8 Dongcheng Recent Development
4.15 Navidea
4.15.1 Navidea Corporation Information
4.15.2 Navidea Description, Business Overview
4.15.3 Navidea Radiopharmaceuticals Products Offered
4.15.4 Navidea Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.15.5 Navidea Radiopharmaceuticals Revenue by Product
4.15.6 Navidea Radiopharmaceuticals Revenue by Application
4.15.7 Navidea Radiopharmaceuticals Revenue by Geographic Area
4.15.8 Navidea Recent Development
5 Breakdown Data by Type
5.1 Global Radiopharmaceuticals Sales by Type (2016-2027)
5.1.1 Global Radiopharmaceuticals Sales by Type (2016-2021)
5.1.2 Global Radiopharmaceuticals Sales Forecast by Type (2022-2027)
5.1.3 Global Radiopharmaceuticals Sales Market Share by Type (2016-2027)
5.2 Global Radiopharmaceuticals Revenue Forecast by Type (2016-2027)
5.2.1 Global Radiopharmaceuticals Revenue by Type (2016-2021)
5.2.2 Global Radiopharmaceuticals Revenue Forecast by Type (2022-2027)
5.2.3 Global Radiopharmaceuticals Revenue Market Share by Type (2016-2027)
5.3 Radiopharmaceuticals Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Radiopharmaceuticals Sales by Application (2016-2027)
6.1.1 Global Radiopharmaceuticals Sales by Application (2016-2021)
6.1.2 Global Radiopharmaceuticals Sales Forecast by Application (2022-2027)
6.1.3 Global Radiopharmaceuticals Sales Market Share by Application (2016-2027)
6.2 Global Radiopharmaceuticals Revenue Forecast by Application (2016-2027)
6.2.1 Global Radiopharmaceuticals Revenue by Application (2016-2021)
6.2.2 Global Radiopharmaceuticals Revenue Forecast by Application (2022-2027)
6.2.3 Global Radiopharmaceuticals Revenue Market Share by Application (2016-2027)
6.3 Radiopharmaceuticals Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Radiopharmaceuticals Market Size YoY Growth 2016-2027
7.2 North America Radiopharmaceuticals Market Facts & Figures by Country
7.2.1 North America Radiopharmaceuticals Sales by Country (2016-2027)
7.2.2 North America Radiopharmaceuticals Revenue by Country (2016-2027)
7.3 North America Radiopharmaceuticals Sales by Type
7.4 North America Radiopharmaceuticals Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Radiopharmaceuticals Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Radiopharmaceuticals Market Facts & Figures by Region
8.2.1 Asia-Pacific Radiopharmaceuticals Sales by Region (2016-2027)
8.2.2 Asia-Pacific Radiopharmaceuticals Revenue by Region (2016-2027)
8.3 Asia-Pacific Radiopharmaceuticals Sales by Type
8.4 Asia-Pacific Radiopharmaceuticals Sales by Application
9 Europe
9.1 Europe Radiopharmaceuticals Market Size YoY Growth 2016-2027
9.2 Europe Radiopharmaceuticals Market Facts & Figures by Country
9.2.1 Europe Radiopharmaceuticals Sales by Country (2016-2027)
9.2.2 Europe Radiopharmaceuticals Revenue by Country (2016-2027)
9.3 Europe Radiopharmaceuticals Sales by Type
9.4 Europe Radiopharmaceuticals Sales by Application
10 Latin America
10.1 Latin America Radiopharmaceuticals Market Size YoY Growth 2016-2027
10.2 Latin America Radiopharmaceuticals Market Facts & Figures by Country
10.2.1 Latin America Radiopharmaceuticals Sales by Country (2016-2027)
10.2.2 Latin America Radiopharmaceuticals Revenue by Country (2016-2027)
10.3 Latin America Radiopharmaceuticals Sales by Type
10.4 Latin America Radiopharmaceuticals Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Radiopharmaceuticals Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Radiopharmaceuticals Market Facts & Figures by Country
11.2.1 Middle East and Africa Radiopharmaceuticals Sales by Country (2016-2027)
11.2.2 Middle East and Africa Radiopharmaceuticals Revenue by Country (2016-2027)
11.3 Middle East and Africa Radiopharmaceuticals Sales by Type
11.4 Middle East and Africa Radiopharmaceuticals Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Radiopharmaceuticals Supply Chain Analysis
12.2 Radiopharmaceuticals Key Raw Materials and Upstream Suppliers
12.3 Radiopharmaceuticals Clients Analysis
12.4 Radiopharmaceuticals Sales Channel and Sales Model Analysis
12.4.1 Radiopharmaceuticals Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Radiopharmaceuticals Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Radiopharmaceuticals Distributors
13 Market Dynamics
13.1 Radiopharmaceuticals Market Drivers
13.2 Radiopharmaceuticals Market Opportunities
13.3 Radiopharmaceuticals Market Challenges
13.4 Radiopharmaceuticals Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
    Table 2. Major Manufacturers of Diagnostic Radioisotopes
    Table 3. Major Manufacturers of Therapeutic Radioisotopes
    Table 4. Global Radiopharmaceuticals Market Size Growth by Application (US$ Million): 2021 VS 2027
    Table 5. Global Radiopharmaceuticals Market Size by Region (US$ Million): 2021 VS 2027
    Table 6. Global Radiopharmaceuticals Sales by Region (2016-2021) & (K Dose)
    Table 7. Global Radiopharmaceuticals Sales Forecast by Region (2022-2027) & (K Dose)
    Table 8. Global Radiopharmaceuticals Revenue by Region (2016-2021) & (US$ Million)
    Table 9. Global Radiopharmaceuticals Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 10. Global Radiopharmaceuticals Sales by Manufacturer (2016-2021) & (K Dose)
    Table 11. Global Radiopharmaceuticals Sales Share by Manufacturer (2016-2021)
    Table 12. Radiopharmaceuticals Revenue by Manufacturer (2016-2021) & (US$ Million)
    Table 13. Radiopharmaceuticals Revenue Share by Manufacturer (2016-2021)
    Table 14. Key Manufacturers Radiopharmaceuticals Price (2016-2021) & (US$/Dose)
    Table 15. Ranking of Global Top Radiopharmaceuticals Manufacturers by Revenue (US$ Million) in 2020
    Table 16. Global Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 17. Global Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceuticals as of 2020)
    Table 18. Radiopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
    Table 19. Manufacturers Radiopharmaceuticals Product Type
    Table 20. Date of International Manufacturers Enter into Radiopharmaceuticals Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Bracco Imaging Corporation Information
    Table 23. Bracco Imaging Description and Business Overview
    Table 24. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 25. Bracco Imaging Radiopharmaceuticals Product
    Table 26. Bracco Imaging Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
    Table 27. Bracco Imaging Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
    Table 28. Bracco Imaging Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
    Table 29. Bracco Imaging Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
    Table 30. Bracco Imaging Recent Development
    Table 31. Bayer Corporation Information
    Table 32. Bayer Description and Business Overview
    Table 33. Bayer Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 34. Bayer Radiopharmaceuticals Product
    Table 35. Bayer Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
    Table 36. Bayer Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
    Table 37. Bayer Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
    Table 38. Bayer Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
    Table 39. Bayer Recent Development
    Table 40. Mallinckrodt Corporation Information
    Table 41. Mallinckrodt Description and Business Overview
    Table 42. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 43. Mallinckrodt Radiopharmaceuticals Product
    Table 44. Mallinckrodt Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
    Table 45. Mallinckrodt Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
    Table 46. Mallinckrodt Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
    Table 47. Mallinckrodt Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
    Table 48. Mallinckrodt Recent Development
    Table 49. Nordion Corporation Information
    Table 50. Nordion Description and Business Overview
    Table 51. Nordion Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 52. Nordion Radiopharmaceuticals Product
    Table 53. Nordion Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
    Table 54. Nordion Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
    Table 55. Nordion Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
    Table 56. Nordion Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
    Table 57. Nordion Recent Development
    Table 58. Triad Isotopes Corporation Information
    Table 59. Triad Isotopes Description and Business Overview
    Table 60. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 61. Triad Isotopes Radiopharmaceuticals Product
    Table 62. Triad Isotopes Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
    Table 63. Triad Isotopes Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
    Table 64. Triad Isotopes Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
    Table 65. Triad Isotopes Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
    Table 66. Triad Isotopes Recent Development
    Table 67. Lantheus Corporation Information
    Table 68. Lantheus Description and Business Overview
    Table 69. Lantheus Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 70. Lantheus Radiopharmaceuticals Product
    Table 71. Lantheus Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
    Table 72. Lantheus Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
    Table 73. Lantheus Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
    Table 74. Lantheus Recent Development
    Table 75. IBA Group Corporation Information
    Table 76. IBA Group Description and Business Overview
    Table 77. IBA Group Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 78. IBA Group Radiopharmaceuticals Product
    Table 79. IBA Group Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
    Table 80. IBA Group Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
    Table 81. IBA Group Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
    Table 82. IBA Group Recent Development
    Table 83. GE Healthcare Corporation Information
    Table 84. GE Healthcare Description and Business Overview
    Table 85. GE Healthcare Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 86. GE Healthcare Radiopharmaceuticals Product
    Table 87. GE Healthcare Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
    Table 88. GE Healthcare Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
    Table 89. GE Healthcare Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
    Table 90. GE Healthcare Recent Development
    Table 91. China Isotope & Radiation Corporation Information
    Table 92. China Isotope & Radiation Description and Business Overview
    Table 93. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 94. China Isotope & Radiation Radiopharmaceuticals Product
    Table 95. China Isotope & Radiation Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
    Table 96. China Isotope & Radiation Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
    Table 97. China Isotope & Radiation Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
    Table 98. China Isotope & Radiation Recent Development
    Table 99. Jubilant Pharma Corporation Information
    Table 100. Jubilant Pharma Description and Business Overview
    Table 101. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 102. Jubilant Pharma Radiopharmaceuticals Product
    Table 103. Jubilant Pharma Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
    Table 104. Jubilant Pharma Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
    Table 105. Jubilant Pharma Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
    Table 106. Jubilant Pharma Recent Development
    Table 107. Eli Lilly Corporation Information
    Table 108. Eli Lilly Description and Business Overview
    Table 109. Eli Lilly Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 110. Eli Lilly Radiopharmaceuticals Product
    Table 111. Eli Lilly Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
    Table 112. Eli Lilly Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
    Table 113. Eli Lilly Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
    Table 114. Eli Lilly Recent Development
    Table 115. Advanced Accelerator Applications Corporation Information
    Table 116. Advanced Accelerator Applications Description and Business Overview
    Table 117. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 118. Advanced Accelerator Applications Radiopharmaceuticals Product
    Table 119. Advanced Accelerator Applications Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
    Table 120. Advanced Accelerator Applications Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
    Table 121. Advanced Accelerator Applications Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
    Table 122. Advanced Accelerator Applications Recent Development
    Table 123. SIEMENS Corporation Information
    Table 124. SIEMENS Description and Business Overview
    Table 125. SIEMENS Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 126. SIEMENS Radiopharmaceuticals Product
    Table 127. SIEMENS Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
    Table 128. SIEMENS Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
    Table 129. SIEMENS Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
    Table 130. SIEMENS Recent Development
    Table 131. Dongcheng Corporation Information
    Table 132. Dongcheng Description and Business Overview
    Table 133. Dongcheng Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 134. Dongcheng Radiopharmaceuticals Product
    Table 135. Dongcheng Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
    Table 136. Dongcheng Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
    Table 137. Dongcheng Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
    Table 138. Dongcheng Recent Development
    Table 139. Navidea Corporation Information
    Table 140. Navidea Description and Business Overview
    Table 141. Navidea Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 142. Navidea Radiopharmaceuticals Product
    Table 143. Navidea Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
    Table 144. Navidea Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
    Table 145. Navidea Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
    Table 146. Navidea Recent Development
    Table 147. Global Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
    Table 148. Global Radiopharmaceuticals Sales Forecast by Type (2022-2027) & (K Dose)
    Table 149. Global Radiopharmaceuticals Revenue by Type (2016-2021) & (US$ Million)
    Table 150. Global Radiopharmaceuticals Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 151. Global Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
    Table 152. Global Radiopharmaceuticals Sales Forecast by Application (2022-2027) & (K Dose)
    Table 153. Global Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)
    Table 154. Global Radiopharmaceuticals Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 155. North America Radiopharmaceuticals Sales by Country (2016-2021) & (K Dose)
    Table 156. North America Radiopharmaceuticals Sales by Country (2022-2027) & (K Dose)
    Table 157. North America Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
    Table 158. North America Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)
    Table 159. North America Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
    Table 160. North America Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
    Table 161. Asia-Pacific Radiopharmaceuticals Sales by Region (2016-2021) & (K Dose)
    Table 162. Asia-Pacific Radiopharmaceuticals Sales by Region (2022-2027) & (K Dose)
    Table 163. Asia-Pacific Radiopharmaceuticals Revenue by Region (2016-2027) & (US$ Million)
    Table 164. Asia-Pacific Radiopharmaceuticals Revenue by Region (2022-2027) & (US$ Million)
    Table 165. Asia-Pacific Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
    Table 166. Asia-Pacific Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
    Table 167. Europe Radiopharmaceuticals Sales by Country (2016-2021) & (K Dose)
    Table 168. Europe Radiopharmaceuticals Sales by Country (2022-2027) & (K Dose)
    Table 169. Europe Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
    Table 170. Europe Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)
    Table 171. Europe Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
    Table 172. Europe Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
    Table 173. Latin America Radiopharmaceuticals Sales by Country (2016-2021) & (K Dose)
    Table 174. Latin America Radiopharmaceuticals Sales by Country (2022-2027) & (K Dose)
    Table 175. Latin America Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
    Table 176. Latin America Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)
    Table 177. Latin America Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
    Table 178. Latin America Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
    Table 179. Middle East and Africa Radiopharmaceuticals Sales by Country (2016-2021) & (K Dose)
    Table 180. Middle East and Africa Radiopharmaceuticals Sales by Country (2022-2027) & (K Dose)
    Table 181. Middle East and Africa Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
    Table 182. Middle East and Africa Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)
    Table 183. Middle East and Africa Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
    Table 184. Middle East and Africa Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
    Table 185. Radiopharmaceuticals Key Raw Materials, Industry Status and Trend
    Table 186. Radiopharmaceuticals Key Raw Materials and Upstream Suppliers
    Table 187. Radiopharmaceuticals Clients Status and Trend
    Table 188. Radiopharmaceuticals Typical Clients
    Table 189. Radiopharmaceuticals Distributors
    Table 190. Key Drivers: Impact Analysis (2022-2027)
    Table 191. Radiopharmaceuticals Market Drivers
    Table 192. Radiopharmaceuticals Market Opportunities
    Table 193. Radiopharmaceuticals Market Challenges
    Table 194. Radiopharmaceuticals Market Restraints
    Table 195. Radiopharmaceuticals Porter’s Five Forces Analysis
    Table 196. Research Programs/Design for This Report
    Table 197. Key Data Information from Secondary Sources
    Table 198. Key Data Information from Primary Sources
List of Figures
    Figure 1. Radiopharmaceuticals Product Picture
    Figure 2. Global Radiopharmaceuticals Sales Market Share by Type in 2021 & 2027
    Figure 3. Diagnostic Radioisotopes Product Picture
    Figure 4. Therapeutic Radioisotopes Product Picture
    Figure 5. Global Radiopharmaceuticals Sales Market Share by Application in 2021 & 2027
    Figure 6. Oncology Examples
    Figure 7. Cardiology Examples
    Figure 8. Other Examples
    Figure 9. Radiopharmaceuticals Report Years Considered
    Figure 10. Global Radiopharmaceuticals Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Radiopharmaceuticals Market Size 2016-2027 (US$ Million)
    Figure 12. Global Radiopharmaceuticals Sales 2016-2027 (K Units)
    Figure 13. Global Radiopharmaceuticals Market Size Market Share by Region: 2021 Versus 2027
    Figure 14. Global Radiopharmaceuticals Sales Market Share Forecast by Region (2016-2027)
    Figure 15. Global Radiopharmaceuticals Revenue Market Share by Region (2016-2027)
    Figure 16. Global Radiopharmaceuticals Sales Share by Manufacturer in 2020
    Figure 17. Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 18. Global Radiopharmaceuticals Sales Market Share Forecast by Type (2016-2027)
    Figure 19. Global Radiopharmaceuticals Revenue Market Share Forecast by Type (2016-2027)
    Figure 20. Radiopharmaceuticals Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
    Figure 21. Global Radiopharmaceuticals Sales Market Share Forecast by Application (2016-2027)
    Figure 22. Global Radiopharmaceuticals Revenue Market Share Forecast by Application (2016-2027)
    Figure 23. Radiopharmaceuticals Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
    Figure 24. North America Radiopharmaceuticals Revenue 2016-2027 (US$ Million)
    Figure 25. North America Radiopharmaceuticals Sales Market Share by Type (2016-2021)
    Figure 26. North America Radiopharmaceuticals Sales Market Share by Application (2016-2021)
    Figure 27. Asia-Pacific Radiopharmaceuticals Revenue 2016-2027 (US$ Million)
    Figure 28. Asia-Pacific Radiopharmaceuticals Sales Market Share by Region (2016-2027)
    Figure 29. Asia-Pacific Radiopharmaceuticals Revenue Market Share by Region (2016-2027)
    Figure 30. Asia-Pacific Radiopharmaceuticals Sales Market Share by Type (2016-2021)
    Figure 31. Asia-Pacific Radiopharmaceuticals Sales Market Share by Application (2016-2021)
    Figure 32. Europe Radiopharmaceuticals Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 33. Europe Radiopharmaceuticals Sales Market Share by Country (2016-2027)
    Figure 34. Europe Radiopharmaceuticals Revenue Market Share by Country (2016-2027)
    Figure 35. Europe Radiopharmaceuticals Sales Market Share by Type (2016-2021)
    Figure 36. Europe Radiopharmaceuticals Sales Market Share by Application (2016-2021)
    Figure 37. Latin America Radiopharmaceuticals Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 38. Latin America Radiopharmaceuticals Sales Market Share by Country (2016-2027)
    Figure 39. Latin America Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
    Figure 40. Latin America Radiopharmaceuticals Sales Market Share by Type (2016-2021)
    Figure 41. Latin America Radiopharmaceuticals Sales Market Share by Application (2016-2021)
    Figure 42. Middle East and Africa Radiopharmaceuticals Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 43. Middle East and Africa Radiopharmaceuticals Sales Market Share by Country (2016-2027)
    Figure 44. Middle East and Africa Radiopharmaceuticals Revenue Market Share by Country (2016-2027)
    Figure 45. Middle East and Africa Radiopharmaceuticals Sales Market Share by Type (2016-2021)
    Figure 46. Middle East and Africa Radiopharmaceuticals Sales Market Share by Application (2016-2021)
    Figure 47. Radiopharmaceuticals Supply Chain (Upstream and Downstream Market)
    Figure 48. Global Production Market Share of Radiopharmaceuticals Raw Materials by Region in 2020
    Figure 49. Radiopharmaceuticals Distribution Channels
    Figure 50. Global Radiopharmaceuticals Percentage 2016-2027: Indirect Sales VS Direct Sales
    Figure 51. Global Radiopharmaceuticals Percentage 2016-2027: Online Sales VS Offline Sales
    Figure 52. Porter's Five Forces Analysis
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows multiple user to access the PDF.
Electronic (PDF)

$11800

This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners

RELATED REPORTS

Global Anti-Anxiety Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-23Q7423
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Real-Time Thermal Cyclers Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-39X13417
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Actarit Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-3Q7887
Fri Feb 23 00:00:00 UTC 2024

Add to Cart

Global Bepotastine Besilate Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-14X7647
Fri Feb 23 00:00:00 UTC 2024

Add to Cart